ClinicalTrials.gov - Information on Clinical Trials and Human Research Studies: Browse: University of Vermont


	Home	\|	Search	\|	Browse	\|	Resources	\|	Help	\|	What's New	\|	About

Browse : By Sponsor : University/Organization : University of Vermont

Include trials that are no longer recruiting patients.

U.S. National Library of Medicine, Contact NLM Customer Service

National Institutes of Health, Department of Health & Human Services

1.	Completed	Alternate Day Buprenorphine Administration, Phase IX - 14 Condition: Opioid-Related Disorders
2.	Completed	Alternate Day Buprenorphine Administration, Phase X - 15 Condition: Opioid-Related Disorders
3.	Completed	Alternate Day Buprenorphine Administration, Phase XI - 16 Condition: Opioid-Related Disorders
4.	Completed	Alternate Day Buprenorphine Administration, Phase XII - 17 Condition: Opioid-Related Disorders
5.	Completed	Alternate-Day Buprenorphine Administration. Phase I - 3 Condition: Opioid-Related Disorders
6.	Completed	Alternate-Day Buprenorphine Administration. Phase II - 4 Condition: Opioid-Related Disorders
7.	Completed	Alternate-Day Buprenorphine Administration. Phase IV - 5 Condition: Opioid-Related Disorders
8.	Completed	Alternate-Day Buprenorphine Administration. Phase VI - 7 Condition: Opioid-Related Disorders
9.	Completed	Alternate-Day Buprenorphine Administration. Phase VII - 8 Condition: Opioid-Related Disorders
10.	Completed	Alternate-Day Buprenorphine Administration. Phase VIII - 9 Condition: Opioid-Related Disorders
11.	Completed	Alternate-Day Buprenorphine. Phase V - 6 Condition: Opioid-Related Disorders
12.	Completed	Buprenorphine Detox with Two Types of Treatment. BBD I - 10 Condition: Opioid-Related Disorders
13.	Completed	Buprenorphine Detox with Two Types of Treatment. BBD II - 11 Condition: Opioid-Related Disorders
14.	Completed	Buprenorphine Detoxification - BBDVI - 19 Condition: Opioid-Related Disorders
15.	Completed	Buprenorphine Detoxification with Two Types of Treatment. BBD III - 12 Condition: Opioid-Related Disorders
16.	Completed	Buprenorphine Detoxification with Two Types of Treatment. BBD IV - 13 Condition: Opioid-Related Disorders
17.	Completed	Buprenorphine Dose Alteration Study - 1 Condition: Opioid-Related Disorders
18.	Completed	Buprenorphine Pharmacology Related to Addiction Treatment - 18 Condition: Opioid-Related Disorders
19.	Completed	Buprenorphine Pharmacology Related to Addiction Treatment - 21 Condition: Opioid-Related Disorders
20.	No longer recruiting	Controlled Trial of 4-Aminosalicylic Acid in Patients with Small Bowel Crohn's Disease Condition: Crohn's Disease
21.	Completed	Gradual vs. Rapid Buprenorphine Detoxification - 2 Condition: Opioid-Related Disorders
22.	Completed	Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis Condition: Ulcerative Colitis
23.	Completed	Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
24.	Completed	Studies of Hereditary Hemorrhagic Telangiectasia Condition: Telangiectasia, Hereditary Hemorrhagic
25.	Completed	Study of the Natural History and Genotype-Phenotype Correlations of Hereditary Hemorrhagic Telangiectasia Patients Condition: Hereditary Hemorrhagic Telangiectasia
26.	No longer recruiting	Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20 Condition: Opioid-Related Disorders